KRAS and colorectal carcinoma: By contrast, in their combined analysis of specific KRAS gene alterations, BRAFV600E status, and MSI, Zlobec et al. found that specific KRAS mutations act as informative prognostic factors in both sporadic and hereditary CRC [54].